pirenzepine has been researched along with Hemorrhagic Shock in 2 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sato, N | 1 |
Quan, LH | 1 |
Kawano, S | 1 |
Kamada, T | 1 |
Abe, H | 1 |
Guarini, S | 1 |
Tagliavini, S | 1 |
Bazzani, C | 1 |
Pasini, M | 1 |
Bertolini, A | 1 |
2 other studies available for pirenzepine and Hemorrhagic Shock
Article | Year |
---|---|
Effect of H2 receptor- and muscarine receptor antagonists and prostaglandin E1 analog on the gastric mucosal hemodynamics and oxygen sufficiency in rats.
Topics: Alprostadil; Animals; Benzodiazepinones; Gastric Mucosa; Hemodynamics; Histamine H2 Antagonists; Mal | 1984 |
Brain M3 muscarinic receptors are involved in the ACTH-induced reversal of hemorrhagic shock.
Topics: Adrenocorticotropic Hormone; Animals; Blood Pressure; Brain Chemistry; Female; Heart Rate; Injection | 1990 |